iNtRON Biotechnology Inc (048530) - Total Liabilities

Latest as of September 2025: ₩4.73 Billion KRW ≈ $3.20 Million USD

Based on the latest financial reports, iNtRON Biotechnology Inc (048530) has total liabilities worth ₩4.73 Billion KRW (≈ $3.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is iNtRON Biotechnology Inc growing its equity to track the company's year-over-year net asset growth rate.

iNtRON Biotechnology Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how iNtRON Biotechnology Inc's total liabilities have evolved over time, based on quarterly financial data. See 048530 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

iNtRON Biotechnology Inc Competitors by Total Liabilities

The table below lists competitors of iNtRON Biotechnology Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Y-Optics Manufacture Co. Ltd KQ:066430	Korea	₩13.17 Billion
XCF Global, Inc. Class A Common Stock NASDAQ:SAFX	USA	$403.51 Million
Wisekey International Holding AG SW:WIHN	Switzerland	CHF53.44 Million
Solidion Technology Inc. NASDAQ:STI	USA	$13.60 Million
Global Education Limited NSE:GLOBAL	India	Rs135.55 Million
Neo-Concept International Group Holdings Limited Ordinary Shares NASDAQ:NCI	USA	$79.58 Million
Bactiguard Holding AB (publ) ST:BACTI-B	Sweden	Skr225.74 Million
LEFORM KLSE:0266	Malaysia	RM217.06 Million

Liability Composition Analysis (2012–2024)

This chart breaks down iNtRON Biotechnology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see iNtRON Biotechnology Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how iNtRON Biotechnology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual total liabilities of iNtRON Biotechnology Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩2.60 Billion ≈ $1.76 Million	+38.37%
2023-12-31	₩1.88 Billion ≈ $1.27 Million	-94.59%
2022-12-31	₩34.78 Billion ≈ $23.57 Million	-33.14%
2021-12-31	₩52.02 Billion ≈ $35.25 Million	+243.19%
2020-12-31	₩15.16 Billion ≈ $10.27 Million	-37.03%
2019-12-31	₩24.07 Billion ≈ $16.31 Million	+53.26%
2018-12-31	₩15.70 Billion ≈ $10.64 Million	+2.07%
2017-12-31	₩15.38 Billion ≈ $10.43 Million	+47.13%
2016-12-31	₩10.46 Billion ≈ $7.09 Million	+76.39%
2015-12-31	₩5.93 Billion ≈ $4.02 Million	-23.17%
2012-12-31	₩7.72 Billion ≈ $5.23 Million	--

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$55.81 Million

₩82.35 Billion KRW

Market Cap Rank

#21432 Global

#1228 in Korea

Share Price

₩2605.00

Change (1 day)

+6.98%

52-Week Range

₩2330.00 - ₩6650.00

All Time High

₩46250.00